-+ 0.00%
-+ 0.00%
-+ 0.00%

GALECTIN THERAPEUTICS PROVIDES REGULATORY UPDATE FOLLOWING FDA WRITTEN RESPONSE AND ANNOUNCES AN ADDITIONAL $10 MILLION LINE OF CREDIT FROM RICHARD E. UIHLEIN SUFFICIENT TO COVER EXPECTED EXPENDITURES THROUGH MARCH 2027

Reuters·12/19/2025 13:00:01

Please log in to view news